Pancreatitis Trial, Recruiting NCT07388420 Sponsor: General Hospital of Shenyang Military Region Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT07388420
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You have been diagnosed with acute pancreatitis caused by high levels of fat (triglycerides) in your blood
  • You have a condition where multiple types of fats in your blood are at unhealthy levels
  • You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You have already received medication to lower your blood fat levels or had a blood-cleaning treatment (such as plasmapheresis) for this condition
  • You have used a medication called evolocumab within the month before being admitted to the hospital
  • You have another serious illness that could significantly affect your chances of survival
  • You have taken part in another drug clinical trial within the past month
  • You are currently pregnant or breastfeeding
  • You have allergic asthma, hives (allergic urticaria), eczema, or a known history of being allergic to multiple medications or foods
  • The trial researchers decide, for any other reason, that participation would not be appropriate for you (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 18909881019

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
General Hospital of Shenyang Military Region
Registry
ClinicalTrials.gov
Start date
2 January 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The TG levels on the 3rd and 7th days after treatment; The rates of achieving TG levels below 5.65 mmol/L and 1.7 mmol/L on the 3rd and 7th days after treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov